miRNAs in Cardiovascular Biology

MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression through inhibition of protein translation or by degradation of specific transcripts. miRNAs can regulate cardiovascular health, and be potential biomarkers or targets in cardiovascular disease. Discover the latest research on miRNAs in Cardiovascular Biology here.

December 4, 2020
Review
Open Access

Advances in Cardiovascular Biomarker Discovery

Biomedicines
Crystal M GhantousAsad Zeidan
January 8, 2021
Review
Open Access

An update on the role of miR-124 in the pathogenesis of human disorders

Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
Soudeh Ghafouri-FardMohammad Taheri
December 5, 2020
Review
Open Access

Roles and regulatory mechanisms of miR-30b in cancer, cardiovascular disease, and metabolic disorders (Review)

Experimental and Therapeutic Medicine
Qing ZhangYongning Xin
January 10, 2021

Circulating cardiovascular microRNAs in critically ill COVID-19 patients Short title: microRNA signatures in COVID-19

European Journal of Heart Failure
Ankita GargThomas Thum
December 5, 2020
Open Access

Protective Effect of miR-204 on Doxorubicin-Induced Cardiomyocyte Injury via HMGB1

Oxidative Medicine and Cellular Longevity
Youyou DuRui Yao
January 15, 2021
Review

A meta-analysis of microRNA expression profiling studies in heart failure

Heart Failure Reviews
Alieh GholaminejadShaghayegh Haghjooy Javanmard
December 19, 2020
Review
Open Access

Autophagy in cardiovascular diseases: role of noncoding RNAs

Molecular Therapy. Nucleic Acids
Jinning GaoKai Shao
December 18, 2020
Review
Open Access

The Cell Type-Specific Functions of miR-21 in Cardiovascular Diseases

Frontiers in Genetics
Beibei DaiChen Chen
December 12, 2020

The antagonistic effects and mechanisms of microRNA-26a action in hypertensive vascular remodeling

British Journal of Pharmacology
Wenqian ZhangDengfeng Gao
December 23, 2020

miR-146a in cardiovascular diseases and sepsis: an additional burden in the inflammatory balance?

Thrombosis and Haemostasis
Ana Belen ArroyoRocio Gonzalez-Conejero

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused as a result of a partial deletion of chromosome 22. Here is the latest research.

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

Alagille Syndrome

Alagille syndrome is a multi-system genetic disorder that can affect the liver, heart, and other parts of the body. It’s characterization includes heart problems, liver damage, jaundice, and xanthomas. Here is the latest research.

Aneurysm

Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Aortic Aneurysm

An aortic aneurysm is the weakening and bulging of the blood vessel wall in the aorta. This causes dilatation of the aorta, which is usually asymptomatic but carries the risk of rupture and hemorrhage. Find the latest research on aortic aneurysms here.

Aortic Coarctation

Aortic coarctation is a congenital condition characterized by narrowing of the aorta. Discover the latest research on this disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

© 2021 Meta ULC. All rights reserved
/feed-previews/mirnas-in-cardiovascular-biology/93b5f618-03e6-4a05-937c-b49ef4db2578